Fund Holdings — Integral Health Asset Management, LLC

Total Portfolio Value:
$1.00B
Total Bought:
$400.22M
Total Sold:
$358.19M
Net Transaction:
+$42.03M
Notable People:
Bhagwan Jay Rao
Securities
▲▼
SharesValue
Q1 2024
▲▼
Q2 2024
▲▼
Change
▲▼
Q1 2024
▲▼
Q2 2024
▲▼
Weight (%)
▲▼
Change
▲▼
Insmed Incorporated(INSM)1,300,0001,550,000+250,000$35.27M$103.85M10.34%+$68.58M
Tenet Healthcare Corporation(THC)425,000500,000+75,000$44.67M$66.52M6.62%+$21.84M
Cytokinetics, Incorporated(CYTK)450,0001,000,000+550,000$31.55M$54.18M5.39%+$22.63M
Boston Scientific Corporation(BSX)600,000650,000+50,000$41.09M$50.06M4.98%+$8.96M
Elevance Health, Inc.(ELV)50,00080,000+30,000$25.93M$43.35M4.31%+$17.42M
Blueprint Medicines Corp210,000340,000+130,000$19.92M$36.65M3.65%+$16.72M
Novartis AGADR(NVS)225,000300,000+75,000$21.76M$31.94M3.18%+$10.17M
Longboard Pharmaceuticals In975,0001,100,000+125,000$21.06M$29.73M2.96%+$8.67M
Merck & Co., Inc.(MRK)235,000235,0000$31.01M$29.09M2.90%-$1.92M
Humana Inc.(HUM)60,00075,000+15,000$20.80M$28.02M2.79%+$7.22M
Encompass Health Corporation(EHC)350,000300,000-50,000$28.90M$25.74M2.56%-$3.17M
Universal Health Services, Inc.CL B(UHS)125,000130,000+5,000$22.81M$24.04M2.39%+$1.23M
Inari Med Inc200,000400,000+200,000$9.60M$19.26M1.92%+$9.66M
Vera Therapeutics, Inc.CL A(VERA)360,000500,000+140,000$15.52M$18.09M1.80%+$2.57M
Crinetics Pharmaceuticals In325,000400,000+75,000$15.21M$17.92M1.78%+$2.70M
Becton, Dickinson and Company(BDX)075,000+75,000$0$17.53M1.74%+$17.53M
The Cigna Group(CI)40,00050,000+10,000$14.53M$16.53M1.65%+$2.00M
Tarsus Pharmaceuticals, Inc.(TARS)590,000590,0000$21.45M$16.04M1.60%-$5.41M
Krystal Biotech, Inc.(KRYS)80,00085,000+5,000$14.23M$15.61M1.55%+$1.38M
Arcellx Inc
COMMON STOCK
255,000275,000+20,000$17.74M$15.18M1.51%-$2.56M
ICON Public Limited CompanySHS(ICLR)45,00045,0000$15.12M$14.11M1.40%-$1.01M
Edwards Lifesciences Corp0150,000+150,000$0$13.86M1.38%+$13.86M
Thermo Fisher Scientific Inc.(TMO)025,000+25,000$0$13.82M1.38%+$13.82M
Quest Diagnostics Incorporated(DGX)0100,000+100,000$0$13.69M1.36%+$13.69M
Viking Therapeutics, Inc.(VKTX)450,000250,000-200,000$36.90M$13.25M1.32%-$23.65M
Revolution Medicines, Inc.(RVMD)420,000325,000-95,000$13.54M$12.61M1.26%-$923.4K
Amgen Inc.(AMGN)040,000+40,000$0$12.50M1.24%+$12.50M
Ionis Pharmaceuticals, Inc.(IONS)0250,000+250,000$0$11.91M1.19%+$11.91M
McKesson Corporation(MCK)020,000+20,000$0$11.68M1.16%+$11.68M
REGENXBIO Inc.(RGNX)760,000950,000+190,000$16.01M$11.12M1.11%-$4.90M
Intra-Cellular Therapies Inc125,000145,000+20,000$8.65M$9.93M0.99%+$1.28M
SanofiADR(SNY)0200,000+200,000$0$9.70M0.97%+$9.70M
MoonLake ImmunotherapeuticsCL A(MLTX)220,000220,0000$11.05M$9.67M0.96%-$1.38M
Neurocrine Biosciences, Inc.(NBIX)150,00070,000-80,000$20.69M$9.64M0.96%-$11.05M
Teleflex Incorporated(TFX)045,000+45,000$0$9.46M0.94%+$9.46M
Eli Lilly and Company(LLY)12,00010,000-2,000$9.34M$9.05M0.90%-$281.7K
Globus Medical, Inc.CL A(GMED)0125,000+125,000$0$8.56M0.85%+$8.56M
Bruker Corporation(BRKR)220,000130,000-90,000$20.67M$8.30M0.83%-$12.37M
CRISPR Therapeutics AGNAMEN AKT(CRSP)220,000150,000-70,000$15.00M$8.10M0.81%-$6.89M
Oscar Health, Inc.CL A(OSCR)500,000500,0000$7.43M$7.91M0.79%+$475.0K
Repligen Corporation(RGEN)50,00060,000+10,000$9.20M$7.56M0.75%-$1.63M
Denali Therapeutics Inc.(DNLI)0325,000+325,000$0$7.55M0.75%+$7.55M
Tenaya Therapeutics, Inc.(TNYA)2,250,0002,325,000+75,000$11.77M$7.21M0.72%-$4.56M
Sana Biotechnology, Inc.(SANA)980,0001,200,000+220,000$9.80M$6.55M0.65%-$3.25M
Elanco Animal Health Incorporated(ELAN)550,000450,000-100,000$8.95M$6.49M0.65%-$2.46M
Mereo BioPharma Group plcADS(MREO)950,0001,775,000+825,000$3.13M$6.39M0.64%+$3.25M
Merus N V165,000100,000-65,000$7.43M$5.92M0.59%-$1.51M
Insulet Corporation(PODD)025,000+25,000$0$5.04M0.50%+$5.04M
QuidelOrtho Corporation(QDEL)0150,000+150,000$0$4.98M0.50%+$4.98M
Relay Therapeutics, Inc.(RLAY)725,000750,000+25,000$6.02M$4.89M0.49%-$1.13M
Surgery Partners, Inc.(SGRY)0200,000+200,000$0$4.76M0.47%+$4.76M
Corbus Pharmaceuticals Holdings, Inc.(CRBP)0100,000+100,000$0$4.53M0.45%+$4.53M
Intuitive Surgical, Inc.(ISRG)50,00010,000-40,000$19.95M$4.45M0.44%-$15.51M
Catalyst Pharmaceuticals Inc0275,000+275,000$0$4.26M0.42%+$4.26M
Roivant Sciences Ltd.SHS(ROIV)600,000400,000-200,000$6.32M$4.23M0.42%-$2.10M
Keros Therapeutics, Inc.(KROS)40,00085,000+45,000$2.65M$3.88M0.39%+$1.24M
Hologic Inc050,000+50,000$0$3.71M0.37%+$3.71M
89bio Inc300,000450,000+150,000$3.49M$3.60M0.36%+$112.5K
Dyne Therapeutics, Inc.(DYN)0100,000+100,000$0$3.53M0.35%+$3.53M
Scholar Rock Holding Corporation(SRRK)325,000400,000+75,000$5.77M$3.33M0.33%-$2.44M
Cabaletta Bio, Inc.(CABA)425,000425,0000$7.25M$3.18M0.32%-$4.07M
Editas Medicine, Inc.(EDIT)450,000675,000+225,000$3.34M$3.15M0.31%-$186.8K
Apogee Therapeutics Inc40,00080,000+40,000$2.66M$3.15M0.31%+$490.0K
Nurix Therapeutics, Inc.(NRIX)0150,000+150,000$0$3.13M0.31%+$3.13M
Fate Therapeutics, Inc.(FATE)200,000850,000+650,000$1.47M$2.79M0.28%+$1.32M
Neurogene Inc.(NGNE)070,000+70,000$0$2.55M0.25%+$2.55M
Spyre Therapeutics, Inc.(SYRE)100,000100,0000$3.79M$2.35M0.23%-$1.44M
Kura Oncology, Inc.(KURA)0100,000+100,000$0$2.06M0.20%+$2.06M
Revance Therapeutics Inc0500,000+500,000$0$1.28M0.13%+$1.28M
4d Molecular Therapeutics In250,0000-250,000$7.96M$0—-$7.96M
AbbVie Inc.(ABBV)135,0000-135,000$24.58M$0—-$24.58M
Agilent Technologies, Inc.(A)30,0000-30,000$4.37M$0—-$4.37M
Align Technology Inc15,0000-15,000$4.92M$0—-$4.92M
Alkermes plcSHS(ALKS)250,0000-250,000$6.77M$0—-$6.77M
Alnylam Pharmaceuticals, Inc.(ALNY)50,0000-50,000$7.47M$0—-$7.47M
Alpine Immune Sciences Inc230,0000-230,000$9.12M$0—-$9.12M
Apellis Pharmaceuticals Inc
COM
150,0000-150,000$8.82M$0—-$8.82M
Autolus Therapeutics plcADS(AUTL)500,0000-500,000$3.19M$0—-$3.19M
Avantor, Inc.(AVTR)500,0000-500,000$12.79M$0—-$12.79M
Axsome Therapeutics, Inc.(AXSM)30,0000-30,000$2.39M$0—-$2.39M
BeOne Medicines AGADR(ONC)40,0000-40,000$6.26M$0—-$6.26M
Cencora Inc50,0000-50,000$12.15M$0—-$12.15M
Charles River Laboratories International, Inc.(CRL)65,0000-65,000$17.61M$0—-$17.61M
The Cooper Companies, Inc.(COO)110,0000-110,000$11.16M$0—-$11.16M
DexCom, Inc.(DXCM)100,0000-100,000$13.87M$0—-$13.87M
Evolent Health, Inc.CL A(EVH)250,0000-250,000$8.20M$0—-$8.20M
Guardant Health, Inc.(GH)150,0000-150,000$3.09M$0—-$3.09M
Inspire Medical Systems, Inc.(INSP)33,0000-33,000$7.09M$0—-$7.09M
Laboratory Corp Amer Hldgs20,0000-20,000$4.37M$0—-$4.37M
MacroGenics, Inc.(MGNX)500,0000-500,000$7.36M$0—-$7.36M
Natera, Inc.(NTRA)50,0000-50,000$4.57M$0—-$4.57M
Penumbra, Inc.(PEN)70,0000-70,000$15.62M$0—-$15.62M
Regeneron Pharmaceuticals, Inc.(REGN)17,0000-17,000$16.36M$0—-$16.36M
Revvity, Inc.(RVTY)50,0000-50,000$5.25M$0—-$5.25M
Sage Therapeutics Inc200,0000-200,000$3.75M$0—-$3.75M
Shockwave Med Inc40,0000-40,000$13.03M$0—-$13.03M
Tandem Diabetes Care, Inc.(TNDM)225,0000-225,000$7.97M$0—-$7.97M
Walgreens Boots Alliance Inc1,300,0000-1,300,000$28.20M$0—-$28.20M
Page 1 of 1
Integral Health Asset Management, LLC — 13F Holdings — Q2 2024 | TickerTrail